11 – 20 of 24
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
Weight loss and body mass index in relation to aspiration in patients treated for head and neck cancer: a long-term follow-up
(
- Contribution to journal › Article
- 2012
-
Mark
The anti-tumour effect of cisplatin and ifosfamide on xenografted squamous cell carcinoma of the head and neck is schedule-dependent.
(
- Contribution to journal › Article
- 2009
-
Mark
Comparison of cisplatin sensitivity and the 18F fluoro-2-deoxy 2 glucose uptake with proliferation parameters and gene expression in squamous cell carcinoma cell lines of the head and neck
(
- Contribution to journal › Article
-
Mark
Clonal chromosome aberrations in a sialoblastoma
(
- Contribution to journal › Letter
- 2008
-
Mark
Fluorescence investigations to classify malignant laryngeal lesions in vivo.
(
- Contribution to journal › Article
-
Mark
Chemorefractory rhabdomyosarcoma treated with radiotherapy, bevacizumab, statins and surgery and maintenance with bevacizumab and chemotherapy.
(
- Contribution to journal › Article
- 2007
-
Mark
2-deoxy-2-[F-18]fluoro-D-glucose uptake and correlation to intratumoral heterogeneity
(
- Contribution to journal › Article
- 2006
-
Mark
p53 mutation and cyclin D1 amplification correlate with cisplatin sensitivity in xenografted human squamous cell carcinomas from head and neck.
(
- Contribution to journal › Article
-
Mark
Differences in estimates of cisplatin-induced cell kill in vitro between colorimetric and cell count/colony assays
(
- Contribution to journal › Article
- 2002
-
Mark
Anaplastic thyroid carcinoma: three protocols combining doxorubicin, hyperfractionated radiotherapy and surgery.
(
- Contribution to journal › Article